Cell & Gene Therapy Drug Delivery Devices Market Size & Forecast 2025–2030: Trends and Growth Insights

Introduction

The Cell & Gene Therapy Drug Delivery Devices Market is undergoing rapid changes due to evolving technologies, consumer behaviors, and regulatory frameworks. This research report explores essential insights, market trends, and forecasts between 2025 and 2030, offering valuable context for businesses, investors, and decision-makers. It is designed to provide a clear understanding of where the market stands and where it’s heading, with the added benefit of downloadable resources and analyst support.

Get Report free sample Copy, Fill the Form Here – https://www.marknteladvisors.com/query/request-sample/cell-gene-therapy-drug-delivery-devices-market.html

What This Report Covers

  • Current Market Size & Forecast (2025–2030)
  • Key Growth Drivers & Challenges
  • Latest Trends & Investment Hotspots
  • Market Segmentation:
  • Competitive Landscape & Player Analysis
  • Opportunities, Risks, and Strategic Recommendations

Current Market Status and Future Projections

Cell & Gene Therapy Drug Delivery Devices Market size was valued at around USD 1.27 billion in 2024 and is projected to reach USD 2.32 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.53% during the forecast period, i.e., 2025-30.

Key Factors Influencing Growth

The market is driven primarily by massive funding by numerous leading players in the technological advancements to bring cost-effective therapies & devices, coupled with the increasing number of FDA approvals for cell & gene therapies & clinical trials. Furthermore, the rising number of FDA Approvals of Cell & Gene Therapies and clinical trials to develop new medical products and provide patients with increased therapeutic choices shall also boost the market in the coming years

Access the Complete Research Report Now – https://www.marknteladvisors.com/research-library/cell-gene-therapy-drug-delivery-devices-market.html

Breakdown by Segments and Geography

By Product Type

  • Sub-retinal Injection Cannula
  • Extension Tube
  • Intravenous Catheter
  • Sterile Insulin Syringe
    • Size 1.0 ML, 31-Gauge Needle
    • Size 0.5 ML, 22-Gauge Needle
  • Pre-Filled Syringe
    • Size 1.0 ML, 22-26 Gauge Needle
    • Size 4.0 ML, 22-26 Gauge Needle
  • Infusion Bags
    • Infusion Bags (Size 10 ML to 50 ML)
    • Infusion Bags (Size 68 ML)
    • Infusion Bags (Size 60 ML)
    • Infusion Bags (Size Up to 65 ML)

By Technology

  • Microchip Technology
  • Nano-Technology
  • Lipid Nanoparticles

By Commercialized Drugs

  • Luxturna
  • Kymriah
  • Yescarta
  • Zolgensma
  • Provenge
  • Strimvelis

Luxturna & Yescarta overpowered the Global Cell & Gene Therapy Drug Delivery Devices Market in 2024.

By End-User

  • Pharmaceuticals & Biotechnology Company
  • Academic & Research Institute
  • Hospitals & Clinics

By Region

  • North America
  • South America
  • Europe
  • Middle East & Africa
  • Asia-Pacific.

North America attained majority of revenue share and is anticipated to prevail the same trend in the forecast period.

Competitive Landscape and Market Positioning

The Cell & Gene Therapy Drug Delivery Devices Market is highly competitive, with both established companies and new entrants contributing to its dynamism. Leading players such as:

  • Amgen Inc.
  • Bausch & Lomb Incorporated
  • Becton, Dickinson and Company
  • Bluebird bio Inc.
  • Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.)
  • Dendreon Pharmaceuticals LLC
  • Helixmith Co. Ltd (ViroMed Co., Ltd)
  • Human Stem Cells Institute
  • Kite Pharma Inc.
  • Kolon TissueGene, Inc.
  • Novartis AG
  • Orchard Therapeutics plc.
  • Pfizer Inc.
  • Renova Therapeutics
  • Spark Therapeutics Inc.
  • uniQure N.V.
  • Vericel Corporation.

are focusing on expanding their product portfolios, enhancing user experiences, and investing in R&D. Recent developments include mergers, acquisitions, strategic partnerships, and geographic expansion. These activities highlight the evolving strategies being adopted to gain market share and respond to shifting consumer needs.

Want insights on competitors or custom segments? Submit Your Inquiry – https://www.marknteladvisors.com/research-library/cell-gene-therapy-drug-delivery-devices-market.html

Strategic Outlook and Analyst Perspective

Looking ahead, the Cell & Gene Therapy Drug Delivery Devices Market is poised for significant transformation. Emerging trends like AI integration, eco-friendly product development, and digitalization are expected to reshape industry dynamics. Analysts recommend that stakeholders keep a close eye on regional shifts, policy developments, and evolving customer preferences. Businesses that remain agile, adopt technology early, and prioritize customer-centric innovation will likely emerge as leaders in this evolving landscape.

Research Methodology We Use

  • Primary research via expert interviews and surveys
  • Secondary data from verified industry sources
  • Top-down & bottom-up estimation
  • Forecasting using time-series models & triangulation

Key Questions Answered

  • What is the current market size of Cell & Gene Therapy Drug Delivery Devices Market?
  • What is the expected growth rate by 2030?
  • Which segments are gaining the most traction?
  • What are the major trends and challenges?
  • Who are the major players, and what are their strategies?
  • Which region holds the highest growth potential?

About Us – MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Other Report:

Contact:

MarkNtel Advisors

Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Contact No: +91 8719999009

Email: sales@marknteladvisors.com

Visit our Website: https://www.marknteladvisors.com

Leave a Reply

Your email address will not be published. Required fields are marked *